SCHEMBL17653273

SCHEMBL17653273

C=C(C)Nc1nc(CCC(C)C)nc2ccccc12

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CCR4 P51679 3/20 0.42
ACHE P22303 8/20 0.40
ACP1 P24666 2/20 0.39
APP P05067 6/20 0.39
BCHE P06276 5/20 0.39
KDM4E B2RXH2 2/20 0.39
ALDH1A1 P00352 2/20 0.39
GAA P10253 1/20 0.39
MAPT P10636 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
TLR7 Q9NYK1 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.37
AAK1 Q2M2I8 1/20 0.37
LMNA P02545 1/20 0.36
TSHR P16473 1/20 0.36
CACNA2D1 P54289 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17653119 0.69 ADORA3 (0.49) SMN1; SMN2AAK1
SCHEMBL17653165 0.65 AAK1 (0.43) KDM4EALDH1A1GAAMAPTL3MBTL1
SCHEMBL17653274 0.64 AAK1 (0.33) CCR4AAK1
SCHEMBL4093298 0.63 APP (0.65) CCR4ACHEACP1APPBCHE
SCHEMBL4095030 0.63 APP (0.60) CCR4ACHEACP1APPBCHE
SCHEMBL16695847 0.62 CCR4 (0.47) CCR4ACP1APPKDM4EALDH1A1
SCHEMBL17653201 0.62 AAK1 (0.40) CCR4KDM4EALDH1A1MAPTSMN1; SMN2
SCHEMBL31649377 0.61 KDM4E (0.56) ACHEBCHEKDM4EALDH1A1MAPT
SCHEMBL4631122 0.61 ALDH1A1 (0.44) ACHEBCHEKDM4EALDH1A1GAA
SCHEMBL4860036 0.60 ACP1 (0.74) ACP1KDM4EALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3200797-A1 QUINAZOLINE-BASED KINASE INHIBITORS Bristol-Myers Squibb Company (US) 2017-08-09 EP disclosed
WO-2016053794-A1 QUINAZOLINE-BASED KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2016-04-07 WO disclosed